“I think it’s fair to characterize PBMs as both arsonists and firefighters in the world of high drug prices.

They are providing a significant amount of savings off of prices that they are partially responsible for bloating in the first place.” Antonio Ciaccia

ajmc.com/view/in-the-pb…

“CVS Health and Cigna’s prices on a selection of so-called specialty generic drugs were at least 24 times higher on average than around what manufacturers charged, according to a Journal analysis of data compiled by 46brooklyn Research, a nonprofit drug-pricing analytics group.”

Working out the strange math and weird consequences of IRA inflation penalties Brian Reid costcurvenews.com/2024/04/11/wor…

Did you say 486%? Why one company thinks such a price hike for its drug is justified pharmalot Antonio Ciaccia Stacie Dusetzina statnews.com/pharmalot/2024…

New drug pricing report:

💊 38 brand list prices went up last month; 1 went down

📈 Triesence price shot up 486%

📉 YoY generic oral solid deflation hit 9.5%

🔪 Alebendazole costs are back up; but Mark Cuban Cost Plus Drug Company is cutting NADAC in half

Receipts: 46brooklyn.com/news/feb-2024-…

We know a few things because we’ve seen a few things. 🤓

'PBMs and health insurance companies don't work to compensate pharmacies in a way that's commensurate with their value to the patient.” - Antonio Ciaccia

Walgreens in West Dayton to close, residents worry about pharmacy access WYSO Public Radio | 91.3 FM wyso.org/business-econo…

Congrats to 46brooklyn board member Scott McGohan on a hell of a career.

In a world of healthcare complexity and opacity, Scott has always been a truth-seeker, and it has served him and his clients well.

Honored to have him as part of our leadership team!

Money from Sick People Part III: Why is U.S. drug pricing policy designed to exploit patients? 46brooklyn.com/news/031424-mo…

In a system that continuously feasts on high drug prices and high patient out-of-pocket costs as subsidies to provide value to others, the race to drug affordability will be a perpetual loser.

How Money from Sick People works: 46brooklyn.com/news/030624-mo…

“No matter the perceived value of the trade-off, the harsh reality remains: when patients don’t receive the benefit of drugmaker discounts, the patient is the source of the generated subsidy that is harvested by someone or something else.”

Our latest: 46brooklyn.com/news/030624-mo…

Check out tomorrow’s The Hill Events Prescribing PBM Reform panel featuring our co-founder and CEO Antonio Ciaccia …ibingpbmreform-thehill.splashthat.com

2024 is off to a wild start for prescription drug prices. Get our latest analysis and all the receipts in our latest drug pricing report. 46brooklyn.com/news/jan-2024-…

CNN’s Tami Luhby digs into 46brooklyn’s dashboards to unearth recent trends in brand drug list price increases and decreases cnn.com/2024/02/15/eco…

What do the drug price changes announced in January tell us? First Report Managed Care Adam J. Fein hmpgloballearningnetwork.com/site/frmc/news…

Why are drug prices in the United States so bloated?

For many medicines, the answer lies below the surface.

More Perfect Union lays out the perverse incentives and dysfunctional system design that inflates prices and sticks sick patients with the tab.

“These legalized bribes directly impact the price consumers pay for drugs.”

abc6onyourside.com/news/local/in-… Darrel Rowland WSYX ABC 6 Antonio Ciaccia

“With government programs getting an 80% discount on Eliquis, lawmakers asking why the price of the drug is so high might get better answers from a mirror than from the pharmaceutical executives themselves.” Antonio Ciaccia

marketwatch.com/story/merck-j-… Eleanor Laise MarketWatch

Vertex's next challenge for pain pill? Cracking a market dominated by cheap opioids Nicole DeFeudis endpts.com/non-opioid-pai…

Brand drugs saw 910 list price increases to kick off 2024, but when factoring in the few list price decreases, the weighted gross impact of the increases is unusually muted – and that’s not even accounting for the growing rebate pie Ken Alltucker usatoday.com/story/news/hea…